Fidia Farmaceutici SpA is an Italian based, integrated pharma company, founded in 1946 and headquartered in AbanoTerme (PD). The company operates in diverse therapeutic areas and has an extensive know-how on hyaluronic acid and its proprietary derivatives, providing a wide array of innovative treatment options for application in joint healthcare and musculoskeletal disorders, with well documented efficacy and safety for patients, consumers and healthcare professionals.
Fidia has developed several products, specifically designed for those who practice sports, based on an innovative hyaluronic acid derivative, fromFidia’s proprietary MO.RE. technology®. This MObileREticulum(MO.RE.) technology gives the product its improved viscoelastic and rheological properties, as well as high resistance to mechanical stress and structure recovery after repeated shocks, thus protecting cartilage and soft tissues against mechanical injuries during sports activities.